Showing results (81-90 of 872) with videos related to
Sort By:
Pageof 88
Cancer Research|June 29, 2012
Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitisKatharina Gerlach, Carolin Daniel, Hans A Lehr, et al.Clinical Oral Investigations|August 12, 2021
Expression of inflammatory mediators in biofilm samples and clinical association in inflammatory bowel disease patients-a preliminary studyMayte Buchbender, Jakob Fehlhofer, Peter Proff, et al.Therapeutic Advances in Gastroenterology|October 9, 2024
Treatment trajectories and outcomes in inflammatory bowel disease: a tertiary single-centre experienceKim Wagner, Tanja M Müller, Francesco Vitali, et al.Journal of Crohn'S & Colitis|June 10, 2025
ST6GAL1 promotes IBD B cell recruitment to the inflamed colon in a CD22-dependent mechanismLi-Juan Liu, Tanja M Müller, Mark Dedden, et al.Clinical and Translational Gastroenterology|May 16, 2022
Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte SubsetsEmily Becker, Anna Schweda, Karen A-M Ullrich, et al.International Journal of Clinical and Experimental Pathology|July 19, 2012
Characterization of lymphoid follicles with red ring signs as first manifestation of early Crohn's disease by conventional histopathology and confocal laser endomicroscopyEkaterina Krauss, Abbas Agaimy, Helmut Neumann, et al.Inflammatory Bowel Diseases|July 15, 2017
Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative ColitisCaroline J Voskens, Anika Fischer, Susanne Roessner, et al.Seminars in Immunology|December 17, 2025
New insights into Th9 cells in inflammatory bowel diseasesMarkus F NeurathScience Translational Medicine|December 14, 2022
Targeting cytokines in inflammatory bowel diseaseMarkus F NeurathNature Reviews. Immunology|March 15, 2024
Strategies for targeting cytokines in inflammatory bowel diseaseMarkus F NeurathPageof 88